TY - JOUR
T1 - Improving outcomes after acute coronary syndrome with rehabilitation and secondary prevention
AU - Briffa, Tom
AU - Chow, Clara K.
AU - Clark, Alexander M.
AU - Redfern, Julie
N1 - Funding Information:
Dr. Chow is supported by a National Health and Medical Research Council of Australia Career Development Fellowship (1033478) co‐funded by the Heart Foundation and a Sydney Medical Foundation Chapman Fellowship. All authors contributed equally to the literature review, synthesis, interpretation, and writing of the manuscript. Dr. Briffa was responsible for preparing the first draft of the manuscript.
PY - 2013/8
Y1 - 2013/8
N2 - Background: International studies suggestal most half of all major coronary episodes annually occur in survivors of acute coronary syndrome(ACS). Objective: A greater focus on medium-and long term ACS management and adherence to proven therapies is essential if out-of-hospital reductions in mortality and morbidity are to be optimized. Methods: A national panel of clinical and research opinion leaders in ACS caremet for 2 days to set future priorities in health care delivery. Results: Lifestyle, control of risk factors, and pre- scription of pharmacological therapies can improve the course of coronary heart disease (CHD) by reduc- ing all-cause and cardiovascular mortality by 15% to 25%. All ACS patients stand to bene?t from rehabi- litation and systematic secondary prevention, how- ever, underutilization and suboptimal adherence to rehabilitation and secondary prevention measures persist globally Results: A range of new initiatives in Australia and elsewhere indicate that time is ripe for change to improve the uptake of preventative treatments in patients after ACS. Key universal drivers of delivering best evidence practice for medium- to long-term care after ACS are economics and locality. Conclusions: Health-service redesign involving all stakeholders will be integral to increasing access, up- take, and adherence to lifestyle, control of risk factors, and pharmacologic therapies shown to improve cardi- ovascular outcomes.
AB - Background: International studies suggestal most half of all major coronary episodes annually occur in survivors of acute coronary syndrome(ACS). Objective: A greater focus on medium-and long term ACS management and adherence to proven therapies is essential if out-of-hospital reductions in mortality and morbidity are to be optimized. Methods: A national panel of clinical and research opinion leaders in ACS caremet for 2 days to set future priorities in health care delivery. Results: Lifestyle, control of risk factors, and pre- scription of pharmacological therapies can improve the course of coronary heart disease (CHD) by reduc- ing all-cause and cardiovascular mortality by 15% to 25%. All ACS patients stand to bene?t from rehabi- litation and systematic secondary prevention, how- ever, underutilization and suboptimal adherence to rehabilitation and secondary prevention measures persist globally Results: A range of new initiatives in Australia and elsewhere indicate that time is ripe for change to improve the uptake of preventative treatments in patients after ACS. Key universal drivers of delivering best evidence practice for medium- to long-term care after ACS are economics and locality. Conclusions: Health-service redesign involving all stakeholders will be integral to increasing access, up- take, and adherence to lifestyle, control of risk factors, and pharmacologic therapies shown to improve cardi- ovascular outcomes.
UR - http://www.scopus.com/inward/record.url?scp=84882975607&partnerID=8YFLogxK
U2 - 10.1016/j.clinthera.2013.07.426
DO - 10.1016/j.clinthera.2013.07.426
M3 - Comment/debate
C2 - 23973041
AN - SCOPUS:84882975607
SN - 0149-2918
VL - 35
SP - 1076
EP - 1081
JO - Clinical Therapeutics
JF - Clinical Therapeutics
IS - 8
ER -